Thomas R. Beck
Executive Partner, F-Prime Capital
pharmaceutical
Medigen Vaccine Biologics Co.
China
Biography
Tom joined F-Prime Capital as an Executive Partner in September, 2007. Most recently, he served as President, Chief Operating Officer at Dyax Corp. Prior to that, he held positions at UCB Pharma (Corporate Vice President, Director of Global Research and Development), CytoMed, Inc (Chairman and Chief Executive Officer), and Enzytech, Inc (President). He began his industry career at Smith Kline and French, where he held positions in both clinical development and business development.
Research Interest
Pharmaceutical science
